ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Ventyx Biosciences Inc

Ventyx Biosciences Inc (VTYX)

2.56
0.07
(2.81%)
2.485
-0.075
(-2.93%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
2.56
Bid
2.51
Ask
2.60
Volume
844,129
2.42 Day's Range 2.595
0.783 52 Week Range 3.39
Market Cap
Previous Close
2.49
Open
2.44
Last Trade
1
@
2.54
Last Trade Time
Financial Volume
$ 2,129,579
VWAP
2.5228
Average Volume (3m)
1,483,579
Shares Outstanding
71,161,201
Dividend Yield
-
PE Ratio
-1.34
Earnings Per Share (EPS)
-1.9
Revenue
-
Net Profit
-135.12M

About Ventyx Biosciences Inc

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. Its lead product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor ... Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. Its lead product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Ventyx Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VTYX. The last closing price for Ventyx Biosciences was $2.49. Over the last year, Ventyx Biosciences shares have traded in a share price range of $ 0.783 to $ 3.39.

Ventyx Biosciences currently has 71,161,201 shares outstanding. The market capitalization of Ventyx Biosciences is $177.19 million. Ventyx Biosciences has a price to earnings ratio (PE ratio) of -1.34.

VTYX Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.3314.7982062782.232.752.22521934912.52004828CS
41.36113.3333333331.22.751.221903412.01611973CS
121.2595.41984732821.312.750.78314835791.55577236CS
260.19918.433224617732.36092.750.78314148461.77832383CS
52-0.45-14.9501661133.013.390.78313404692.05418364CS
156-11.8-82.172701949914.3647.25080.783139924810.02114023CS
260-16.09-86.27345844518.6547.25080.783118516210.19688074CS

VTYX - Frequently Asked Questions (FAQ)

What is the current Ventyx Biosciences share price?
The current share price of Ventyx Biosciences is $ 2.56
How many Ventyx Biosciences shares are in issue?
Ventyx Biosciences has 71,161,201 shares in issue
What is the market cap of Ventyx Biosciences?
The market capitalisation of Ventyx Biosciences is USD 177.19M
What is the 1 year trading range for Ventyx Biosciences share price?
Ventyx Biosciences has traded in the range of $ 0.783 to $ 3.39 during the past year
What is the PE ratio of Ventyx Biosciences?
The price to earnings ratio of Ventyx Biosciences is -1.34
What is the reporting currency for Ventyx Biosciences?
Ventyx Biosciences reports financial results in USD
What is the latest annual profit for Ventyx Biosciences?
The latest annual profit of Ventyx Biosciences is USD -135.12M
What is the registered address of Ventyx Biosciences?
The registered address for Ventyx Biosciences is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Ventyx Biosciences website address?
The website address for Ventyx Biosciences is www.ventyxbio.com
Which industry sector does Ventyx Biosciences operate in?
Ventyx Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RBNERobin Energy Ltd
$ 13.85
(313.43%)
101.81M
OPOceanPal Inc
$ 1.63
(125.45%)
80.28M
LGHLWLion Group Holding Ltd
$ 0.0052
(116.67%)
6.87M
NEONNeonode Inc
$ 16.83
(68.47%)
4.78M
ICONIcon Energy Corporation
$ 2.90
(62.01%)
59.04M
SBETSharpLink Gaming Inc
$ 9.2275
(-71.63%)
41.92M
AIHSSenmiao Technology Ltd
$ 0.381
(-63.01%)
16.8M
CHSNChanson International Holding
$ 0.22
(-60.00%)
15.15M
KWMK Wave Media Ltd
$ 2.91
(-50.43%)
2.59M
JZXNJiuzi Holdings Inc
$ 1.56
(-46.39%)
2.24M
HCTIHealthcare Triangle Inc
$ 0.0201
(-33.00%)
856.89M
GNLNGreenlane Holdings Inc
$ 0.0101
(-34.42%)
792.34M
CGBSCrown LNG Holdings Ltd
$ 0.1104
(31.43%)
788.42M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.655
(3.81%)
246.13M
NVDANVIDIA Corporation
$ 141.97
(-2.09%)
180.81M

VTYX Discussion

View Posts
makinezmoney makinezmoney 3 days ago
$VTYX: Big #UOA on July $2.50calls.............

Looks like some news on Parkinsons Drug is coming............ these were loaded at $0.15prem

Keep an eye on it.




GO $VTYX
πŸ‘οΈ0
glenn1919 glenn1919 7 days ago
VTYX.............................https://stockcharts.com/h-sc/ui?s=VTYX&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 2 weeks ago
VTYX....................................https://stockcharts.com/h-sc/ui?s=VTYX&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 3 weeks ago
VTYX.........................https://stockcharts.com/h-sc/ui?s=VTYX&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Monksdream Monksdream 1 month ago
VTYX under $2

πŸ‘οΈ0
Monksdream Monksdream 2 months ago
VTYX, recent 52 week low
πŸ‘οΈ0
FAILURE TO DELIVER FAILURE TO DELIVER 2 months ago
Had such hope for this,but it seems the science must be garbage otherwise insiders would be buying open market at these low prices.
πŸ‘οΈ0
glenn1919 glenn1919 5 months ago
VTYX........................https://stockcharts.com/h-sc/ui?s=VTYX&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
FAILURE TO DELIVER FAILURE TO DELIVER 5 months ago
Can’t figure this one in the short term.
Insiders continue to acquire shares and
it goes down but more bullish than ever long term.
πŸ‘οΈ0
FAILURE TO DELIVER FAILURE TO DELIVER 6 months ago
Alot of insider buying going on with this one.
Own 54K shares at a 2.25 average based on these recent transactions. Something brewing.
FTD
πŸ‘οΈ0
glenn1919 glenn1919 6 months ago
VTYX....................https://stockcharts.com/h-sc/ui?s=VTYX&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Invest-in-America Invest-in-America 6 months ago
Boy, some SAGE advice there, Bro!!! (And let alone the looming CRASH in that "Bitcoin" --- that digital GAMBLING CHIP, which represents NOTHING!! Not a sports team, not a commodity, not a precious metal, not an industry, not a nation, NOT ANYTHING!!! GOOD LUCK to those who 'INVEST" in any type of CRYPTO NOTHINGNESS!!! And ask the likes of the FDIC, etc., if they will INSURE your Bitcoin or Crypto nothingness account!!!)
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 months ago
nothing wrong with doing what he does....hes trying to help.....but hes not trading them...we are in a stock market boom....look A ROUND...ENJOY IT WHILE IT LASTS...BECAUSE in late jan...its all coming down
πŸ‘οΈ0
Invest-in-America Invest-in-America 6 months ago
I'm not CERTAIN as to WHAT he does with those charts, his money, & moreover I could care less. However, the STOCKS that his charts REPRESENT are sometimes decent money-makers. The main thing that I do NOT like about him is the HUGE NUMBER of mere CHARTS that he tosses in everybody's face every day --- really absurd!!
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 months ago
he does not trade dude...he just posts those charts
πŸ‘οΈ0
Invest-in-America Invest-in-America 6 months ago
VTYX: I just try to be 'courteous', as they say; since some iHubers post CHARTS only, without any commentary. (YOUR posts are great, because you always post bold COMMENTARY & opinion, of some sort.)
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 months ago
he follows me lol
πŸ‘οΈ0
Invest-in-America Invest-in-America 6 months ago
THANKS, Glenn, for ALL of those several heads-ups!!
πŸ‘οΈ0
glenn1919 glenn1919 6 months ago
VTYX........................https://stockcharts.com/h-sc/ui?s=VTYX&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 months ago
VTYX EXOLODING
πŸ‘οΈ0
glenn1919 glenn1919 7 months ago
VTYX...................................https://stockcharts.com/h-sc/ui?s=VTYX&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 8 months ago
VTYX.....................https://stockcharts.com/h-sc/ui?s=VTYX&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
FAILURE TO DELIVER FAILURE TO DELIVER 9 months ago
Performing like crap on great news. smh
πŸ‘οΈ0
Invest-in-America Invest-in-America 9 months ago
VTYX: Nice news, from big PHARMA firm.
πŸ‘οΈ0
Awl416 Awl416 9 months ago
Ventyx Biosciences Announces $27 Million Strategic Investment from Sanofi
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
VTYX under $3
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
VTYX under $5
πŸ‘οΈ0
FAILURE TO DELIVER FAILURE TO DELIVER 1 year ago
This will be taking off again tomorrow.
πŸ‘οΈ0
FAILURE TO DELIVER FAILURE TO DELIVER 1 year ago
This will be taking off again tomorrow.
πŸ‘οΈ0
DTGoody DTGoody 1 year ago
Keep in mind they are also selling 100 million Shares or 300 million Dollars' worth of securities:

The base prospectus immediately follows this explanatory note. The specific terms of any securities to be offered pursuant to the base prospectus other than the shares under the sales agreement will be specified in a prospectus supplement to the base prospectus. The specific terms of the securities to be issued and sold under the sales agreement are specified in the sales agreement prospectus that immediately follows the base prospectus. The $100,000,025 of common stock that may be offered, issued and sold under the sales agreement prospectus is included in the $300.0 million of securities that may be offered, issued and sold by us under the base prospectus. If the sales agreement with Jefferies LLC is terminated, any portion of the $100,000,025 of common stock included in the sales agreement prospectus that is not sold pursuant to the sales agreement will become available for sale in other offerings pursuant to the base prospectus and a corresponding prospectus supplement, and if no shares are sold under the sales agreement, the full $100,000,025 of securities may be sold in other offerings pursuant to the base prospectus and a corresponding prospectus supplement.


https://www.otcmarkets.com/filing/html?id=17263201&guid=o0d-kFHS95BWJth
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
VTYX: Yep!! Several days ago now, I posted 3-times to that board specifically to call that clown "JobyNimble" --- Orion's official CENSOR --- every disparaging epithet known to mankind!!!

PS: I'm doing VERY well today on @EBS.
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
$MEDS the stock are you really banned on ORIONS board
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
VTYX: I am BANNED from the Orion's board, so I could NOT reply to your inquiry from there, to wit, "DID YOU TAKE YOUR MEDS THIS MORNING?" In any event, YES I did, Bro!!! A spoon full of LSD!!! And boy, I just HATE when this happens!!!!!
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
VTYX: And THAT's how ya do it, Boss!!! CONGRATS!!!
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
MISSED THE 4.80 DIP


ARGGGGG
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
BACK IN 5.81 AFTER SELLING 7.07
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
VTYX: "Hey, Rocky!! Watch me pull a rabbit out of my HAT!!!" ("AGAIN??")
πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
$VTYX VTYX - $VTYX

Piper and Jefferies saying Ventyx Bio. (VTYX) might be the next big weight loss drug citing a new publication showing NLRP3 has significant weight loss similar to GLP-1. ---------------------------
New published industry data suggests NLRP3 inhibition in the CNS…— Marc Lehman (@markflowchatter) February 21, 2024
πŸ‘οΈ0
FAILURE TO DELIVER FAILURE TO DELIVER 1 year ago
Well it took awhile to hit,but much better than I expected.
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
VTYX: Winner of this day????? (Hmmm)

Nothing buy BAD news for MONTHS about this Firm --- trashed studies, etc. --- but TODAY will likely hit Jupiter within 20-minutes from liftoff!!
πŸ‘οΈ0
FAILURE TO DELIVER FAILURE TO DELIVER 1 year ago
4 insiders exercised option buys at 2.49 for a total of 530K shares.
I’m in.
πŸ‘οΈ0
Golden Cross Golden Cross 2 years ago
Ventyx Biosciences to Participate in the 35th Annual Piper Sandler Healthcare Conference
November 21 2023 - 04:05PM

Alert
Print
Share On Facebook

Ventyx Biosciences, Inc. (Nasdaq: VTYX) (β€œVentyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in the upcoming 35th Annual Piper Sandler Healthcare Conference.
Event: 35th Annual Piper Sandler Healthcare Conference
Location: New York, NY
Date: Tuesday, November 28, 2023
Time: 1:30-1:55 PM ET
A webcast of the presentation will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com. A webcast replay will also be available on this website shortly after conclusion of the event for thirty days.

About Ventyx Biosciences

Ventyx is a clinical-stage biopharmaceutical company focused on developing innovative oral medicines for patients living with autoimmune and inflammatory disorders. We believe our ability to efficiently discover and develop differentiated drug candidates will allow us to address important unmet medical need with novel oral therapies that can shift immunology markets from injectable to oral drugs. Our current pipeline includes internally discovered clinical programs targeting TYK2, S1P1R and NLRP3, positioning us to become a leader in the development of oral immunology therapies. Ventyx is headquartered in San Diego, California. For more information about Ventyx, please visit www.ventyxbio.com.

Investor Relations Contact
Patti Bank
Managing Director
ICR Westwicke
(415) 513-1284
IR@ventyxbio.com
πŸ‘οΈ0
steez steez 2 years ago
Looking good
πŸ‘οΈ0
DTGoody DTGoody 2 years ago
That would teach the shorts a valuable lesson!
πŸ‘οΈ0
DTGoody DTGoody 2 years ago
The shorts got a Fu'ken Death Grip on this! It looks like they may lose control of the stock today if this can break above 2.80 it's game on!!
πŸ‘οΈ0
steez steez 2 years ago
Will ad more this week
πŸ‘οΈ0
Golden Cross Golden Cross 2 years ago
Looks like a play in this one
👍️ 1 💲 1 ✔️ 1
DTGoody DTGoody 2 years ago
Right now I am playing December and March call options. With these prices at $2.40 I am thinking about actually buying the stock.

The prices are insanely cheap right now with them having 300 million in cash.
πŸ‘οΈ0
goingUPagain goingUPagain 2 years ago
This stock should be at $15pps!
👍️ 1 💲 1 ♥️ 1 ✔️ 1
DTGoody DTGoody 2 years ago
Everything looks good to go here. I am not sure why this was taken down from $15 to $2.50 on just one of their pipeline drugs being pulled by the company in order to save their cash burn rate?

They still have four other drugs in the pipeline here.

With $300 million in cash this will get them all the way through 2025.

I believe this selloff was an overreaction and a very nice bounce is in order here.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock